BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23028140)

  • 1. Autoinhibition of CYP3A4 leads to important role of CYP2C8 in imatinib metabolism: variability in CYP2C8 activity may alter plasma concentrations and response.
    Filppula AM; Neuvonen M; Laitila J; Neuvonen PJ; Backman JT
    Drug Metab Dispos; 2013 Jan; 41(1):50-9. PubMed ID: 23028140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates.
    Filppula AM; Laitila J; Neuvonen PJ; Backman JT
    Br J Pharmacol; 2012 Apr; 165(8):2787-98. PubMed ID: 22014153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes.
    Nebot N; Crettol S; d'Esposito F; Tattam B; Hibbs DE; Murray M
    Br J Pharmacol; 2010 Nov; 161(5):1059-69. PubMed ID: 20977456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemfibrozil impairs imatinib absorption and inhibits the CYP2C8-mediated formation of its main metabolite.
    Filppula AM; Tornio A; Niemi M; Neuvonen PJ; Backman JT
    Clin Pharmacol Ther; 2013 Sep; 94(3):383-93. PubMed ID: 23657159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro.
    Wang JS; DeVane CL
    Drug Metab Dispos; 2003 Jun; 31(6):742-7. PubMed ID: 12756206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CYP2C8*3 polymorphism on in vitro metabolism of imatinib to N-desmethyl imatinib.
    Khan MS; Barratt DT; Somogyi AA
    Xenobiotica; 2016; 46(3):278-87. PubMed ID: 26161459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors.
    Jaakkola T; Laitila J; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):44-51. PubMed ID: 16867170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of CYP3A4 inhibition on the steady-state pharmacokinetics of imatinib.
    van Erp NP; Gelderblom H; Karlsson MO; Li J; Zhao M; Ouwerkerk J; Nortier JW; Guchelaar HJ; Baker SD; Sparreboom A
    Clin Cancer Res; 2007 Dec; 13(24):7394-400. PubMed ID: 18094422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro: effect of fibrates and rifampicin.
    Kajosaari LI; Laitila J; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2005 Oct; 97(4):249-56. PubMed ID: 16176562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
    Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
    Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reevaluation of the microsomal metabolism of montelukast: major contribution by CYP2C8 at clinically relevant concentrations.
    Filppula AM; Laitila J; Neuvonen PJ; Backman JT
    Drug Metab Dispos; 2011 May; 39(5):904-11. PubMed ID: 21289076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-drug Interaction between Losartan and Paclitaxel in Human Liver Microsomes with Different CYP2C8 Genotypes.
    Mukai Y; Senda A; Toda T; Hayakawa T; Eliasson E; Rane A; Inotsume N
    Basic Clin Pharmacol Toxicol; 2015 Jun; 116(6):493-8. PubMed ID: 25424246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
    Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
    Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
    Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically-Based Pharmacokinetic Predictions of the Effect of Curcumin on Metabolism of Imatinib and Bosutinib: In Vitro and In Vivo Disconnect.
    Adiwidjaja J; Boddy AV; McLachlan AJ
    Pharm Res; 2020 Jun; 37(7):128. PubMed ID: 32529309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes.
    Projean D; Morin PE; Tu TM; Ducharme J
    Xenobiotica; 2003 Aug; 33(8):841-54. PubMed ID: 12936704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are drug labels static or dynamic?
    Seminerio MJ; Ratain MJ
    Clin Pharmacol Ther; 2013 Sep; 94(3):302-4. PubMed ID: 23963217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
    Karam WG; Goldstein JA; Lasker JM; Ghanayem BI
    Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway-dependent inhibition of paclitaxel hydroxylation by kinase inhibitors and assessment of drug-drug interaction potentials.
    Wang Y; Wang M; Qi H; Pan P; Hou T; Li J; He G; Zhang H
    Drug Metab Dispos; 2014 Apr; 42(4):782-95. PubMed ID: 24476576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes.
    Wang JS; Neuvonen M; Wen X; Backman JT; Neuvonen PJ
    Drug Metab Dispos; 2002 Dec; 30(12):1352-6. PubMed ID: 12433802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.